Attached files

file filename
10-K - FORM 10-K - Cardiac Science CORPv55247e10vk.htm
EX-31.1 - EX-31.1 - Cardiac Science CORPv55247exv31w1.htm
EX-21.1 - EX-21.1 - Cardiac Science CORPv55247exv21w1.htm
EX-23.1 - EX-23.1 - Cardiac Science CORPv55247exv23w1.htm
EX-32.2 - EX-32.2 - Cardiac Science CORPv55247exv32w2.htm
EX-10.4 - EX-10.4 - Cardiac Science CORPv55247exv10w4.htm
EX-31.2 - EX-31.2 - Cardiac Science CORPv55247exv31w2.htm
EX-10.20 - EX-10.20 - Cardiac Science CORPv55247exv10w20.htm
EX-10.13 - EX-10.13 - Cardiac Science CORPv55247exv10w13.htm
EX-10.17 - EX-10.17 - Cardiac Science CORPv55247exv10w17.htm
EX-10.22 - EX-10.22 - Cardiac Science CORPv55247exv10w22.htm
EX-10.5 - EX-10.5 - Cardiac Science CORPv55247exv10w5.htm
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Annual Report of Cardiac Science Corporation (the Company) on Form 10-K for the fiscal year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, David L. Marver, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
     (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
         
By:  /s/ David L. Marver  
  David L. Marver   
  Chief Executive Officer   
Date: March 15, 2010